1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ankylosing Spondylitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ankylosing Spondylitis Clinical Trials by Region
2.2.2 Average Enrollment of Ankylosing Spondylitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ankylosing Spondylitis Treatment, 2019

3. Region wise Ankylosing Spondylitis Clinical Trials
3.1 Asia Pacific Ankylosing Spondylitis Clinical Trials by Country
3.2 Europe Ankylosing Spondylitis Clinical Trials by Country
3.3 North America Ankylosing Spondylitis Clinical Trials by Country
3.4 Middle East and Africa Ankylosing Spondylitis Clinical Trials by Country
3.5 South and Central America Ankylosing Spondylitis Clinical Trials by Country

4. Ankylosing Spondylitis Clinical Trial Trends
4.1 Start Year wise Ankylosing Spondylitis Clinical Trials
4.2 Phase wise Ankylosing Spondylitis Clinical Trials
4.3 Trial Status wise Ankylosing Spondylitis Clinical Trials
4.4 Trial Type wise Ankylosing Spondylitis Clinical Trials

5. Ankylosing Spondylitis Average Enrollment Trends
5.1 Average Enrollment in Ankylosing Spondylitis Trials by Year
5.2 Average Enrollment in Ankylosing Spondylitis Trials by Phase
5.3 Average Enrollment in Ankylosing Spondylitis Trials by Status
5.4 Average Enrollment in Ankylosing Spondylitis Trials by Type of Trial

6. Companies Participating in Ankylosing Spondylitis Clinical Trials
6.1 Ankylosing Spondylitis Trials by Sponsor Type
6.2 Ankylosing Spondylitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ankylosing Spondylitis Trials- Phase 1
7.2 Ankylosing Spondylitis Trials- Phase 2
7.3 Ankylosing Spondylitis Trials- Phase 3
7.4 Ankylosing Spondylitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ankylosing Spondylitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 9: Ankylosing Spondylitis Clinical Trials by Phase
Figure 10: Ankylosing Spondylitis Clinical Trials by Trial Status
Figure 11: Ankylosing Spondylitis Clinical Trials by Type
Figure 12: Ankylosing Spondylitis Clinical Trials by Sponsor Type
Figure 13: Ankylosing Spondylitis Clinical Trials by Leading Sponsors
Figure 14: Ankylosing Spondylitis Average Enrollment by Phase
Figure 15: Ankylosing Spondylitis Average Enrollment by Trial Status
Figure 16: Ankylosing Spondylitis Average Enrollment by Type
Figure 17: Ankylosing Spondylitis- Average Enrolment by Type of Sponsors
Figure 18: Ankylosing Spondylitis- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Ankylosing Spondylitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 7: North America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ankylosing Spondylitis Average Enrollment by Phase
Table 15: Ankylosing Spondylitis Average Enrollment by Trial Status
Table 16: Ankylosing Spondylitis Average Enrollment by Type
Table 17: Ankylosing Spondylitis- Average Enrolment by Type of Sponsors
Table 18: Ankylosing Spondylitis- Enrolment by Leading Sponsors

Companies mentioned
AbbVie Inc, Amgen Inc, Biocad, C. H. Boehringer Sohn AG & Co KG, Johnson & Johnson, Merck & Co Inc, Novartis AG, Pamplona Capital Management LLP, Pfizer Inc, UCB SA